MOH Earnings Prediction
The chart below shows how MOH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MOH sees a +1.30% change in stock price 10 days leading up to the earnings, and a +2.67% change 10 days following the report. On the earnings day itself, the stock moves by +0.08%. This data can give you a slight idea of what to expect for the next quarter's release.
MOH Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
10.50B
16.04%
1.54%
Gross Margin
13.79%
-19.54%
-13.60%
Operating Margin
3.60%
3.15%
-20.35%
Net Margin
2.39%
0.00%
-24.13%
EPS
4.44
19.35%
-21.42%
No Data Available
MOH Earnings Analysis
Molina Healthcare Inc Corporation (MOH.N) Earnings Conference Call
Positive
Adjusted EPS Growth: Adjusted earnings per share for Q4 2024 reached $5.05, contributing to a full year adjusted EPS of $22.65, reflecting an 8.5% year-over-year growth.
Premium Revenue Increase: Full year premium revenue for 2024 was reported at $38.6 billion, marking a significant 19% increase compared to the previous year.
Pre-Tax Margin Performance: The full year consolidated pre-tax margin was 4.3%, aligning well within the long-term target range, demonstrating effective cost management.
ConnectiCare Acquisition Revenue Boost: The acquisition of ConnectiCare is expected to generate approximately $1.2 billion in revenue, enhancing the company's marketplace segment.
2025 Premium Revenue Projection: Projected premium revenue for 2025 is approximately $42 billion, indicating a 9% growth from 2024, with adjusted EPS guidance set at a minimum of $24.5, representing a solid foundation for future growth.
Negative
MCR Exceeds Expectations: Consolidated MCR for Q4 was 90.2%, exceeding expectations due to higher medical costs, particularly in Medicaid and Medicare segments, indicating ongoing cost pressures.
Medicaid MCR Analysis: Medicaid MCR for the full year was reported at 90.3%, which is 80 basis points above the long-term target range, reflecting elevated medical cost trends and utilization pressures.
Medicare Cost Management Challenges: Medicare MCR for Q4 was 93.8%, significantly above the long-term range, driven by increased utilization of LTSS and pharmacy services, indicating challenges in cost management.
Operating Cash Flow Decline: Operating cash flow for the full year 2024 was $644 million, lower than 2023, primarily due to risk corridor payments, suggesting cash flow pressures impacting operational flexibility.
Medicaid MCR Projections: The company anticipates a 2025 Medicaid MCR of 89.9%, which is 90 basis points above the high end of the long-term range, indicating continued elevated medical cost trends and potential margin pressures.
MOH FAQs
How does MOH typically perform around its earnings report dates?
Is Molina Healthcare Inc (MOH) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MOH Earning Call Sentiment
Earnings call transcript: Molina Healthcare Q4 2024 misses EPS, stock drops 10%
MOH.N
2.9%Positive
The earnings call highlights strong financial performance with significant growth initiatives, positive EPS and revenue guidance, and effective cost management. The Q&A section reveals management's confidence in handling MLR trends and financial forecasts, though some responses lacked clarity. Despite minor uncertainties, the overall sentiment remains optimistic, supported by solid financial metrics and strategic growth plans. The absence of negative catalysts and the potential for improved operating cash flow in 2025 further bolster a positive outlook for the stock price.
